LOESTRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Loestrin, and when can generic versions of Loestrin launch?
Loestrin is a drug marketed by Teva Branded Pharm and is included in five NDAs.
The generic ingredient in LOESTRIN is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LOESTRIN?
- What are the global sales for LOESTRIN?
- What is Average Wholesale Price for LOESTRIN?
Summary for LOESTRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 5 |
| Drug Prices: | Drug price information for LOESTRIN |
| DailyMed Link: | LOESTRIN at DailyMed |


